John Maki of Vicus Therapeutics joined us for World Orphan Drug Congress USA 2015 to present about ‘Bringing Next Generation Immunotherapy to Cancer’ .
Download the presentation now to learn more about:
- Vicus’ next generation targets
- First multi-pathway neuro-immune modulator for cancer
- VT-122 pipeline in a product (today)
- VT-122 pipeline in a product (2018)
…and much more!
Get your copy here!
To find out more about Vicus Therapeutics’ next generation immunotherapy , join us at World Orphan Drug Congress USA 2016 April 20-22 in Washington, DC.